Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001534120-26-000011
Filing Date
2026-03-23
Accepted
2026-03-23 07:02:46
Documents
87
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K avtx-20251231.htm   iXBRL 10-K 2402228
2 EX-23.1 ex-2312025.htm EX-23.1 17510
3 EX-31.1 ex-3112025.htm EX-31.1 10375
4 EX-31.2 ex-3122025.htm EX-31.2 10163
5 EX-32.1 ex-3212025.htm EX-32.1 10900
11 GRAPHIC avtx-20251231_g1.jpg GRAPHIC 44236
  Complete submission text file 0001534120-26-000011.txt   10852384

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avtx-20251231.xsd EX-101.SCH 74056
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avtx-20251231_cal.xml EX-101.CAL 104935
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avtx-20251231_def.xml EX-101.DEF 440159
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avtx-20251231_lab.xml EX-101.LAB 911664
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avtx-20251231_pre.xml EX-101.PRE 665995
91 EXTRACTED XBRL INSTANCE DOCUMENT avtx-20251231_htm.xml XML 1239853
Mailing Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087
Business Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37590 | Film No.: 26779869
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)